These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 11166326

  • 1. S 14506: novel receptor coupling at 5-HT(1A) receptors.
    Milligan G, Kellett E, Dacquet C, Dubreuil V, Jacoby E, Millan MJ, Lavielle G, Spedding M.
    Neuropharmacology; 2001 Mar; 40(3):334-44. PubMed ID: 11166326
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Correlation between low/high affinity ratios for 5-HT(1A) receptors and intrinsic activity.
    Assié MB, Cosi C, Koek W.
    Eur J Pharmacol; 1999 Dec 10; 386(1):97-103. PubMed ID: 10611469
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nad-299 antagonises 5-HT-stimulated and spiperone-inhibited [35S]GTPgammaS binding in cloned 5-HT1A receptors.
    Jerning E, Rosqvist S, Mohell N.
    J Recept Signal Transduct Res; 2002 Dec 10; 22(1-4):483-95. PubMed ID: 12503636
    [Abstract] [Full Text] [Related]

  • 7. The putative <<silent>> 5-HT(1A) receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT(1A) receptors.
    Cosi C, Koek W.
    Eur J Pharmacol; 2000 Jul 28; 401(1):9-15. PubMed ID: 10915831
    [Abstract] [Full Text] [Related]

  • 8. Mutation in a protein kinase C phosphorylation site of the 5-HT1A receptor preferentially attenuates Ca2+ responses to partial as opposed to higher-efficacy 5-HT1A agonists.
    Wurch T, Colpaert FC, Pauwels PJ.
    Neuropharmacology; 2003 Jun 28; 44(7):873-81. PubMed ID: 12726819
    [Abstract] [Full Text] [Related]

  • 9. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors.
    Otano A, García-Osta A, Ballaz S, Frechilla D, Del Río J.
    Br J Pharmacol; 1999 Dec 28; 128(8):1691-8. PubMed ID: 10588924
    [Abstract] [Full Text] [Related]

  • 10. 5-HT(1A) receptor agonist-antagonist binding affinity difference as a measure of intrinsic activity in recombinant and native tissue systems.
    Watson J, Collin L, Ho M, Riley G, Scott C, Selkirk JV, Price GW.
    Br J Pharmacol; 2000 Jul 28; 130(5):1108-14. PubMed ID: 10882396
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.
    Orús L, Pérez-Silanes S, Oficialdegui AM, Martínez-Esparza J, Del Castillo JC, Mourelle M, Langer T, Guccione S, Donzella G, Krovat EM, Poptodorov K, Lasheras B, Ballaz S, Hervías I, Tordera R, Del Río J, Monge A.
    J Med Chem; 2002 Sep 12; 45(19):4128-39. PubMed ID: 12213056
    [Abstract] [Full Text] [Related]

  • 12. Aging alters in a region-specific manner serotonin transporter sites and 5-HT(1A) receptor-G protein interactions in hamster brain.
    Duncan MJ, Hensler JG.
    Neuropharmacology; 2002 Jul 12; 43(1):36-44. PubMed ID: 12213257
    [Abstract] [Full Text] [Related]

  • 13. Imipramine but not 5-HT(1A) receptor agonists or neuroleptics induces adaptive changes in hippocampal 5-HT(1A) and 5-HT(4) receptors.
    Zahorodna A, Tokarski K, Bijak M.
    Eur J Pharmacol; 2002 May 17; 443(1-3):51-7. PubMed ID: 12044792
    [Abstract] [Full Text] [Related]

  • 14. Inactivation of 5-HT(1A) receptors in hippocampal and cortical homogenates.
    Alper RH, Nelson DL.
    Eur J Pharmacol; 2000 Feb 25; 390(1-2):67-73. PubMed ID: 10708708
    [Abstract] [Full Text] [Related]

  • 15. S 15535 and WAY 100,635 antagonise 5-HT-stimulated [35S]GTP gamma S binding at cloned human 5-HT1A receptors.
    Newman-Tancredi A, Chaput C, Verrièle L, Millan MJ.
    Eur J Pharmacol; 1996 Jun 20; 307(1):107-11. PubMed ID: 8831111
    [Abstract] [Full Text] [Related]

  • 16. Antibody capture assay reveals bell-shaped concentration-response isotherms for h5-HT(1A) receptor-mediated Galpha(i3) activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signaling.
    Newman-Tancredi A, Cussac D, Marini L, Millan MJ.
    Mol Pharmacol; 2002 Sep 20; 62(3):590-601. PubMed ID: 12181435
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
    Khawaja X, Ennis C, Minchin MC.
    Life Sci; 1997 Sep 20; 60(9):653-65. PubMed ID: 9048968
    [Abstract] [Full Text] [Related]

  • 18. Characterization of 5-HT1A receptor-mediated [35S]GTPgammaS binding in rat hippocampal membranes.
    Alper RH, Nelson DL.
    Eur J Pharmacol; 1998 Feb 19; 343(2-3):303-12. PubMed ID: 9570480
    [Abstract] [Full Text] [Related]

  • 19. Site-directed mutations in the third intracellular loop of the serotonin 5-HT(1A) receptor alter G protein coupling from G(i) to G(s) in a ligand-dependent manner.
    Malmberg A, Strange PG.
    J Neurochem; 2000 Sep 19; 75(3):1283-93. PubMed ID: 10936212
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the functional heterologous desensitization of hypothalamic 5-HT(1A) receptors after 5-HT(2A) receptor activation.
    Zhang Y, D'Souza D, Raap DK, Garcia F, Battaglia G, Muma NA, Van de Kar LD.
    J Neurosci; 2001 Oct 15; 21(20):7919-27. PubMed ID: 11588165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.